HEPATIC DEFICIENCY OF SPHINGOSINE KINASE 2 EXACERBATES BILE DUCT LIGATION-INDUCED CHOLESTATIC LIVER INJURY

被引:0
|
作者
Tai, Yun-Ling [1 ]
Zhou, Huiping [2 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23284 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
169
引用
收藏
页码:120A / 121A
页数:2
相关论文
共 50 条
  • [1] HEPATIC SPHINGOSINE KINASE 2 PROTECTS AGAINST BILE DUCT LIGATION-INDUCED CHOLESTATIC LIVER INJURY
    Wu, Jilin
    Wang, Yanyan
    Ge, Pu
    Tai, Yunling
    Zhang, Yuan
    Zhao, Derrick
    Wang, Xuan
    Gurley, Emily
    Hylemon, Phillip
    Campos, Guilherme
    Zhou, Huiping
    GASTROENTEROLOGY, 2020, 158 (06) : S1277 - S1277
  • [2] Copper Deficiency Exacerbates Bile Duct Ligation-Induced Liver Injury and Fibrosis in Rats
    Song, Ming
    Zhou, Zhanxiang
    Chen, Theresa
    Zhang, Jingwen
    McClain, Craig J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (01): : 298 - 306
  • [3] Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats
    Pan, Pin-Ho
    Wang, Ya-Yu
    Lin, Shih-Yi
    Liao, Su-Lan
    Chen, Yu-Fang
    Huang, Wei-Chi
    Chen, Chun-Jung
    Chen, Wen-Ying
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [4] Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis
    Song, Ming
    Song, Zhenyuan
    Barve, Shirish
    Zhang, Jingwen
    Chen, Theresa
    Liu, Marcia
    Arteel, Gavin E.
    Brewer, George J.
    McClain, Craig J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (02): : 409 - 416
  • [5] Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo
    Cao, Fei
    Liu, Peng
    Zhang, Xianbin
    Hu, Yanfen
    Dong, Xin
    Bao, Haidong
    Kong, Lingkai
    Wang, Lei
    Gong, Peng
    BIOSCIENCE REPORTS, 2019, 39
  • [6] The role of PPARγ in bile duct ligation-induced hepatic injury in rats
    Kitagawa, Tomomi
    Yokoyama, Yukihiro
    Kawai, Toru
    Kawai, Kiyotaka
    Watanabe, Katsutaka
    Nagino, Masato
    HEPATOLOGY, 2007, 46 (04) : 339A - 339A
  • [7] CHOP deficiency protects against bile duct ligation-induced cholestatic liver injury by reduction of intestinal barrier dysfunction and inflammatory response
    Liu, Runping
    Li, Xiaojiaoyang
    Aoki, Hiroaki
    Sun, Lixin
    Ning, Yanxia
    Zhang, Luyong
    Takabe, Kauaki
    Pandak, William M.
    Hylemon, Phillip
    Zhou, Huiping
    HEPATOLOGY, 2016, 64 : 97A - 97A
  • [8] Induction of lipopolysaccharide binding protein (LBP) in the bile duct ligation-induced cholestatic liver
    Fukuda, T
    Ikejima, K
    Honda, H
    Nishiyama, D
    Hirose, M
    Enomoto, N
    Kitamura, T
    Takei, Y
    Sato, N
    HEPATOLOGY, 2000, 32 (04) : 200A - 200A
  • [9] Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
    Wei, Shizhang
    Ma, Xiao
    Niu, Ming
    Wang, Ruilin
    Yang, Tao
    Wang, Dan
    Wen, Jianxia
    Li, Haotian
    Zhao, Yanling
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] ER stress-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury
    Liu, Runping
    Li, Xiaojiaoyang
    Pandak, William M.
    Hylemon, Phillip
    Zhou, Huiping
    HEPATOLOGY, 2017, 66 : 935A - 935A